Home / Cardiovascular system / Pindolol
ATC C07AA03 · Beta Blocking Agents, Non-Selective
Pindolol shortage
As of 2 Nov 2026, Pindolol has a reported shortage in 2 of the 15 countries we track (United States, Canada), covering 4 products from 2 companies.
Countries2/15
Products4packs or presentations
Companies21 listed
Short since1 May 202518 months ago
Earliest returnnot givencompany estimate
Main reasonNot stated
United States2 products shortCanada2 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageAustraliaNo reported shortage
Timeline
United StatesCanada
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Sun Pharma SUNPHARMA · NSE
Compared with similar medicines
ATC group C07AA · Beta Blocking Agents, Non-SelectiveAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Pindolol, Tablet, 10 mg (NDC 57664-656-88) discontinuation | Sun Pharmaceutical Industries, Inc. | 30 Jan 2026 | not given | Not stated |
| US | Pindolol, Tablet, 5 mg (NDC 57664-655-88) discontinuation | Sun Pharmaceutical Industries, Inc. | 30 Jan 2026 | not given | Not stated |
| CA | VISKEN (Bottles of 100) | XEDITON PHARMACEUTICALS INC | 1 May 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | VISKEN (Bottles of 100) | XEDITON PHARMACEUTICALS INC | 1 May 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.